SF3B1 and neoplasm: Splice events that are both outliers compared to normal tissues and differentially spliced between SF3B1 mutant and wild-type tumors are promising candidates as tumor-specific neoantigens, as many of these are predicted to generate novel sequences through frame disruptions and insertions in the tumor-specific isoforms (Fig. 5C).